SP2509

SP2509
Item number Size Datasheet Manual SDS Delivery time Quantity Price
SYN-1212-M001 1 mg -

3 - 9 business days*

158.00€
SYN-1212-M005 5 mg -

3 - 9 business days*

329.00€
SYN-1212-M010 10 mg -

3 - 9 business days*

514.00€
SYN-1212-M050 50 mg -

3 - 9 business days*

-
SYN-1212-M100 100 mg -

3 - 9 business days*

-
 
Soluble in DMSO. LSD1 is a promising target for cancer therapy. Epigenetic control of histone... more
Product information "SP2509"
Soluble in DMSO. LSD1 is a promising target for cancer therapy. Epigenetic control of histone methylation is frequently associated with oncogenesis and LSD1 is overexpressed in many types of cancer. siRNA knockdown of LSD1 has been shown to suppress growth of cancer cells. SP-2528 is a selective and reversible LSD1 inhibitor with an IC(50) of 10nM. SP-2528 demonstrates a high specificity for LSD1, with no effect on MAOi. Target: LSD1
Keywords: SP-2509
Supplier: SYNkinase
Supplier-Nr: 1212

Properties

Application: LSD1 inhibitor
MW: 437,9 D
Formula: C19H20ClN3O5S
Purity: >95%
Format: Solid

Database Information

CAS : 1423715-09-6| Find alternatives
KEGG ID : K11450 | Find alternatives

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SP2509"
Write a review
or to review a product.
Viewed